Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3

被引:86
作者
Chu, XY
Huskey, SEW
Braun, MP
Sarkadi, B
Evans, DC
Evers, R
机构
[1] Merck & Co Inc, Dept Drug Metab, Rahway, NJ 07065 USA
[2] Natl Med Ctr, Inst Haematol & Immunol, Budapest, Hungary
关键词
D O I
10.1124/jpet.103.062091
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ethinylestradiol (EE) is one of the key constituents of oral contraceptives. Major metabolites of EE in humans are the glucuronide and sulfate conjugates, EE-3-O-glucuronide (EE-G) and EE-3-O-sulfate (EE-S). In the present study, transport of EE-G and EE-S by the human multidrug resistance proteins MRP1, MRP2, and MRP3 was investigated using inside-out membrane vesicles, isolated from Sf9 cells expressing human MRP1, MRP2, or MRP3. Vesicular uptake studies showed that EE-G was not a substrate for MRP1, whereas an ATP-dependent and saturable transport of [H-3] EE-G was observed in MRP2 (K-m of 35.1+/-3.5 muM) and MRP3 (K-m of 9.2+/-2.3 muM) containing vesicles. EE-S was not transported by either MRP1, MRP2, or MRP3. However, low concentrations of EE-S stimulated MRP2-mediated uptake of ethacrynic acid glutathione. EE-S also stimulated MRP2 and MRP3-mediated uptake of 17beta-estradiol- 17beta-D-glucuronide. Interestingly, EE-S stimulated strongly MRP2- and MRP3-mediated uptake of EE-G by increasing its apparent transport affinity, whereas no reciprocal stimulation of EE-S uptake by EE-G was observed. These data indicate that EE-S allosterically stimulates MRP2- and MRP3-mediated transport of EE-G and is not cotransported with EE-G. Our studies demonstrate specific active transport of a pharmacologically relevant drug conjugate by human MRP2 and MRP3, involving complex interactions with other organic anions. We also suggest that caution needs to be taken when using only competition studies as screening tools to identify substrates or inhibitors of MRP-mediated transport.
引用
收藏
页码:156 / 164
页数:9
相关论文
共 42 条
[1]   Transport activity of human MRP3 expressed in Sf9 cells: Comparative studies with rat MRP3 [J].
Akita, H ;
Suzuki, H ;
Hirohashi, T ;
Takikawa, H ;
Sugiyama, Y .
PHARMACEUTICAL RESEARCH, 2002, 19 (01) :34-41
[2]   THE GUT WALL METABOLISM OF ETHINYLESTRADIOL AND ITS CONTRIBUTION TO THE PRE-SYSTEMIC METABOLISM OF ETHINYLESTRADIOL IN HUMANS [J].
BACK, DJ ;
BRECKENRIDGE, AM ;
MACIVER, M ;
ORME, M ;
PURBA, HS ;
ROWE, PH ;
TAYLOR, I .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (03) :325-330
[3]   Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions [J].
Bakos, É ;
Evers, R ;
Sinkó, E ;
Váradi, A ;
Borst, P ;
Sarkadi, B .
MOLECULAR PHARMACOLOGY, 2000, 57 (04) :760-768
[4]   Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions [J].
Bodó, A ;
Bakos, E ;
Szeri, F ;
Váradi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (26) :23529-23537
[5]   A family of drug transporters: The multidrug resistance-associated proteins [J].
Borst, P ;
Evers, R ;
Kool, M ;
Wijnholds, J .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (16) :1295-1302
[6]   Mammalian ABC transporters in health and disease [J].
Borst, P ;
Elferink, RO .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :537-592
[7]  
Chu XY, 1997, J PHARMACOL EXP THER, V281, P304
[8]  
COLE SPC, 1994, CANCER RES, V54, P5902
[9]  
Cole SPC, 1998, BIOESSAYS, V20, P931, DOI 10.1002/(SICI)1521-1878(199811)20:11<931::AID-BIES8>3.0.CO
[10]  
2-J